Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 13,113
+14 (0.11%)
Aug 11, 2025, 11:30 AM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 168.20 billion as of August 8, 2025. Its market cap has increased by 56.62% in one year.
Market Cap
168.20B
Enterprise Value
167.38B
Revenue
13.30B
Ranking
n/a
PE Ratio
95.49
Stock Price
13,113.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 168.20B, an increase of 50,088.00%. That is a compound annual growth rate of 28.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 168.20B | -4.50% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | 14.04B | 161.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.50B |
| Divi's Laboratories | 1,570.11B |
| Cipla | 1,200.16B |
| Apollo Hospitals Enterprise | 1,018.64B |
| Mankind Pharma | 1,018.24B |
| Zydus Lifesciences | 941.99B |
| Fortis Healthcare | 677.46B |
| Aurobindo Pharma | 605.25B |